An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)
Status:
Completed
Trial end date:
2018-11-17
Target enrollment:
Participant gender:
Summary
The Phase II study consisted of two parts, part 1 is open label, randomized, controlled and
exploratory dose finding in children aged between 2 and 6 years infected with S. mansoni.
Part 2 investigated efficacy and safety with the selected formulation and dosage in S.
mansoni infected children aged between 3 months - 2 years.